145149-86-6

Upstream product

• 153541-58-3 1-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 441017-58-9 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl iodide 
• 503173-63-5 1-O-acetyl-2,3,4-tri-O-benzyl-6-O-tert-butyldiphenylsilyl-α-D-glucopyranoside 
• 58479-67-7 methyl 2,3,4-tri-O-benzyl-6-O-tert-butyldiphenylsilyl-α-D-glucopyranoside 
• 58479-62-2 (2R,3S,4S,5R,6S)-2-(tert-Butyl-diphenyl-silanyloxymethyl)-6-methoxy-tetrahydro-pyran-3,4,5-triol 
• 3879-79-6 methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside 
• 4356-77-8 acetyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 4356-77-8 1,6-di-O-acetyl-2,3,4-tri-O-benzyl-D-glucopyranose 
• 108-24-7 acetic anhydride 
• 38184-15-5 methyl 6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 97-30-3 methyl-alpha-D-glucopyranoside 

Downstream Products

• 145149-77-5 O-(6-O-Acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-2,3,4-tri-O-benzyl-α-D-glucopyranosyl chloride 
• 441018-00-4 Acetic acid (2R,3R,4S,5R,6S)-3,4,5-tris-benzyloxy-6-((2R,3R,4S,5R,6R)-3,4,5-tris-benzyloxy-6-iodo-tetrahydro-pyran-2-ylmethoxy)-tetrahydro-pyran-2-ylmethyl ester 
• 145149-88-8 Methyl O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-2,3-di-O-benzoyl-4-deoxy-α-D-xylo-hexopyranoside 
• 145149-89-9 Methyl O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-2,4-di-O-benzyl-3-deoxy-α-D-ribo-hexopyranoside 
• 145149-91-3 Methyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1->6)-4-deoxy-α-D-xylo-hexopyranoside 

Relevant academic research and scientific papers

HEPARANASE INHIBITORS FOR TREATMENT OF DIABETES

Anti-heparanase compounds for the treatment of diabetes are described. The anti-heparanase compounds are high affinity, synthetic glycopolymers that result in minimal anticoagulant activity. Stereoselective fluorinated forms of these compounds are also pr

HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS

Anti-heparanase compounds for the treatment of cancer are described. The anti-heparanase compounds are high affinity, synthetic glycopolymers that result in minimal anticoagulant activity. Stereoselective fluorinated forms of these compounds are also prov

Phenanthroline-Catalyzed Stereoretentive Glycosylations

Carbohydrates are essential moieties of many bioactive molecules in nature. However, efforts to elucidate their modes of action are often impeded by limitations in synthetic access to well-defined oligosaccharides. Most of the current methods rely on the

Solution- and solid-phase oligosaccharide synthesis using glucosyl iodides: a comparative study

Glycosyl iodide donors have been used in both solid- and solution-phase syntheses yielding α-(1->6)-linked glucosyl oligomers in highly efficient protocols. While the solid-phase strategy offers advantages in terms of ease of purification, it requires a t

Solution-Phase Hexasaccharide Synthesis Using Glucosyl Iodides

(Equation Presented) Oligosaccharides composed of 1,6-glucosyl residues have been prepared from glucosyl iodides. The reactions are highly stereoselective, giving the α-glycosides as the only isolated products in yields ranging from 84% to 94%. Oligomer s